Literature DB >> 15817776

Phenotype switching affects biofilm formation by Candida parapsilosis.

Sean F Laffey1, Geraldine Butler1.   

Abstract

Generation of biofilms by the pathogenic yeast Candida parapsilosis is correlated closely with disease. The phenomenon of phenotype switching in 20 isolates of C. parapsilosis was examined and the relationship with biofilm development was investigated. Four stable and heritable phenotypes were identified--crepe, concentric, smooth and crater. Cells from crepe and concentric phenotypes are almost entirely pseudohyphal, whilst cells from smooth and crater phenotypes are mostly yeast-like. The pseudohyphae from concentric phenotypes are approximately 45 % wider than those from crepe cells. The cell size of the smooth phenotype is smaller than those of the other three phenotypes. On polystyrene surfaces, the concentric phenotype generates up to twofold more biofilm than the crepe and crater phenotypes. Smooth phenotypes generate the least biofilm. Concentric phenotypes also invade agar surfaces more than the crepe and crater phenotypes, whilst smooth phenotypes do not invade at all. The smooth phenotype, however, grows significantly faster than the others. The quorum-sensing molecule farnesol inhibits formation of biofilms by the crepe, concentric and crater phenotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817776     DOI: 10.1099/mic.0.27739-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  44 in total

1.  Thin aggregative fimbriae and cellulose enhance long-term survival and persistence of Salmonella.

Authors:  A P White; D L Gibson; W Kim; W W Kay; M G Surette
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

Review 2.  Plasticity of Candida albicans Biofilms.

Authors:  David R Soll; Karla J Daniels
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

Review 3.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

4.  Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells.

Authors:  Margarida Martins; Mariana Henriques; Joana Azeredo; Sílvia M Rocha; Manuel A Coimbra; Rosário Oliveira
Journal:  Eukaryot Cell       Date:  2007-11-02

5.  Characterization of phenotypic switching in Cryptococcus neoformans biofilms.

Authors:  Luis R Martinez; David C Ibom; Arturo Casadevall; Bettina C Fries
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

Review 6.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Normal human gingival epithelial cells sense C. parapsilosis by toll-like receptors and module its pathogenesis through antimicrobial peptides and proinflammatory cytokines.

Authors:  Raouf Bahri; Sèverine Curt; Dalila Saidane-Mosbahi; Mahmoud Rouabhia
Journal:  Mediators Inflamm       Date:  2010-05-03       Impact factor: 4.711

8.  Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p.

Authors:  Célia Ferreira; Sónia Silva; Fábio Faria-Oliveira; Eva Pinho; Mariana Henriques; Cândida Lucas
Journal:  BMC Microbiol       Date:  2010-09-15       Impact factor: 3.605

9.  Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis.

Authors:  Srisuda Pannanusorn; Bernardo Ramírez-Zavala; Heinrich Lünsdorf; Birgitta Agerberth; Joachim Morschhäuser; Ute Römling
Journal:  Eukaryot Cell       Date:  2013-12-02

10.  The role of Candida albicans AP-1 protein against host derived ROS in in vivo models of infection.

Authors:  Charu Jain; Kelly Pastor; Arely Y Gonzalez; Michael C Lorenz; Reeta P Rao
Journal:  Virulence       Date:  2013-01-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.